HM13 and nonpapillary renal cell carcinoma: HM13 copy number gains were present in 13.2% of stage 1 ccRCC tumors, and in this subset, copy number gain was positively associated with HM13 expression (stage 1: Log2FC = 0.67, p = 2.80 × 10−6).